3ZC
6-({7-[(1-aminocyclopropyl)methoxy]-6-methoxyquinolin-4-yl}oxy)-N-methylnaphthalene-1-carboxamide
Find entries where: 3ZC
is present as a standalone ligand in 1 entries
Chemical Component Summary | |
---|---|
Name | 6-({7-[(1-aminocyclopropyl)methoxy]-6-methoxyquinolin-4-yl}oxy)-N-methylnaphthalene-1-carboxamide |
Identifiers | 6-[7-[(1-azanylcyclopropyl)methoxy]-6-methoxy-quinolin-4-yl]oxy-N-methyl-naphthalene-1-carboxamide |
Formula | C26 H25 N3 O4 |
Molecular Weight | 443.494 |
Type | NON-POLYMER |
Isomeric SMILES | CNC(=O)c1cccc2c1ccc(c2)Oc3ccnc4c3cc(c(c4)OCC5(CC5)N)OC |
InChI | InChI=1S/C26H25N3O4/c1-28-25(30)19-5-3-4-16-12-17(6-7-18(16)19)33-22-8-11-29-21-14-24(23(31-2)13-20(21)22)32-15-26(27)9-10-26/h3-8,11-14H,9-10,15,27H2,1-2H3,(H,28,30) |
InChIKey | CUDVHEFYRIWYQD-UHFFFAOYSA-N |
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 58 |
Chiral Atom Count | 0 |
Bond Count | 62 |
Aromatic Bond Count | 22 |
Drug Info: DrugBank
DrugBank ID | DB11845 |
---|---|
Name | Lucitanib |
Groups | investigational |
Description | Lucitanib has been used in trials studying the treatment of ER+, MBC, SCLC, HER2+, and NSCLC, among others. |
Synonyms | Lucitanib |
Categories | Heterocyclic Compounds, Fused-Ring |
CAS number | 1058137-23-7 |
Related Resource References
Resource Name | Reference |
---|---|
Pharos | CHEMBL2220486 |
PubChem | 25031915 |
ChEMBL | CHEMBL2220486 |
ChEBI | CHEBI:65209 |